Dr. Chong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2400Fax+1 214-645-2405
Education & Training
- Henry Ford Health/Henry Ford HospitalResidency, Dermatology, 2005 - 2008
- Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 2004 - 2005
- Johns Hopkins University School of MedicineClass of 2004
Certifications & Licensure
- TX State Medical License 2008 - 2026
- MI State Medical License 2004 - 2008
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus Start of enrollment: 2006 Dec 01
- Low-dose UVA1 Radiation in Cutaneous Lupus Patients Start of enrollment: 2012 Sep 01
- Study of Anti-Malarials in Incomplete Lupus Erythematosus Start of enrollment: 2017 Dec 28
Publications & Presentations
PubMed
- Systemic lupus erythematosus is a risk factor for having multiple subtypes of cutaneous lupus erythematosus.Grace Lu, Larry Steven Brown, Benjamin F Chong
Lupus. 2024-12-21 - Smoking status is a negative predictor of six-month cutaneous lupus activity trends: A prospective cohort study.Tyler B Cepica, Lillian Xie, Daniella F Faden, Caroline J Stone, Rui Feng
Journal of the American Academy of Dermatology. 2024-12-06 - Incidence and Prevalence of Atherosclerotic Cardiovascular Disease in Cutaneous Lupus Erythematosus.Henry W Chen, Jialiang Liu, Donghan M Yang, Yang Xie, Eric D Peterson
JAMA Dermatology. 2024-12-04
Journal Articles
- Mock Recruitment for the Study of Antimalarials in Incomplete Lupus Erythematosus TrialBenjamin F Chong, Cristina Arriens, David R Karp, Judith A James, Arthritis Care & Research
Press Mentions
- Autoimmune Skin Condition Linked to Higher Risk of Heart DiseaseJanuary 13th, 2025
- Horizon Therapeutics Plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus ErythematosusJanuary 4th, 2023
- Reviewers' List December 2017October 3rd, 2017
- Join now to see all
Professional Memberships
- Member
- Fellow
- Clinical Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: